Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients
This study is currently recruiting participants.
Verified July 2012
by Ludwig-Maximilians - University of Munich
Study NCT01384994 Information provided by Ludwig-Maximilians - University of Munich
First Received on May 2, 2011. Last Updated on July 5, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
KRAS Wildtype
After Resection of Liver Metastases
Additional conditions recognized in this trial
Colorectal Neoplasms
Liver Neoplasms
Neoplasm Metastasis
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Rectal Diseases
Interventions listed in this trial
Folic Acid
5-FU
Oxaliplatin
Panitumumab
Additional drug interventions recognized in this trial
Antibodies, Monoclonal
Fluorouracil
Hematinics
Vitamin B Complex
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Substances
Hematologic Agents
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamins
Sponsors listed in this trial
PD Dr. med. Volker Heinemann
Amgen
Back to top of Main Content
